Siolta Therapeutics Raises $12 Million in Series C Financing for Clinical Development
March 12, 2024 04:00 AM Pacific Daylight Time SAN CARLOS, Calif.–(BUSINESS WIRE)–Siolta Therapeutics, a clinical-stage biotech company, has announced the completion of a $12 million Series C financing round. The round, co-led by SymBiosis and…